A national registry of haemoglobinopathies in Greece: Deducted demographics, trends in mortality and affected births

Annals of Hematology

Volumn 91, Issue 9, 2012, Pages 1451-1458

  Voskaridou, Ersi ^a   Ladis, Vasilis ^a   Kattamis, Antonis ^b   Hassapopoulou, Eleni ^c   Economou, Marina ^d   Kourakli, Alexandra ^e   Maragkos, Konstantinos ^f   Kontogianni, Kalliopi ^g   Lafioniatis, Stilianos ^h   Vrettou, Eleni ⁱ   Koutsouka, Freideriki ^j   Papadakis, Alexandros ^k   Mihos, Andreas ^l   Eftihiadis, Eftihios ^m   Farmaki, Kallistheni ⁿ   Papageorgiou, Ourania ^o   Tapaki, Georgia ^p   Maili, Polixeni ^q   Theohari, Maria ^r   Drosou, Marouso ^s   Kartasis, Zafeiris ^t   Aggelaki, Maria ^u   Basileiadi, Artemis ^v   Adamopoulos, Ioannis ^w   Lafiatis, Ioannis ^x   Galanopoulos, Athanasios ^y   Xanthopoulidis, Georgios ^z   Dimitriadou, Efthimia ^aa   Mprimi, Agapi ^ab   Stamatopoulou, Maria ^ac   Haile, Elanso Damba ^ad   Tsironi, Maria ^ae   Anastasiadis, Athanasios ^af   Kalmanti, Maria ^ag   Papadopoulou, Margarita ^ah   Panori, Evaggelia ^ai   Dimoxenou, Peristera ^aj   Tsirka, Antigoni ^ak   Georgakopoulos, Dimitrios ^al   Drandrakis, Pantelis ^am   Dionisopoulou, Dionisia ^an   Ntalamaga, Androniki ^ao   Davros, Ioannis ^ap   Karagiorga, Markisia ^aq   more..

^a LAIKO GENERAL HOSPITAL   (Greece)

^b Children's University Hospital of Athens 'Agia Sofia   (Greece)

^c AHEPA UNIVERSITY HOSPITAL   (Greece)

^d University Hospital of Thessaloniki Ippokrateion   (Greece)

^e UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^f University Hospital Hippocration of Athens   (Greece)

^g UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^h General Hospital 'Achilopouleio of Volos   (Greece)

ⁱ DRAKOPOULEIO Blood Centre of Athens   (Greece)

^j UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^k Venizelion General Hospital   (Greece)

^l General Hospital of Corfu   (Greece)

^m General Hospital of Karditsa   (Greece)

ⁿ General Hospital of Corinthos   (Greece)

^o Karamandaneio Hospital of Patras   (Greece)

^p Children's Hospital of Pentelis   (Greece)

^q General Hospital of Rhodes   (Greece)

^r Children's Hospital Pan and Aglaia Kyriakou of Athens   (Greece)

^s General Hospital Agios Panteleimon of Nikea   (Greece)

^t General Hospital of Chalkida   (Greece)

^u General Hospital Agios Pavlos of Thessaloniki   (Greece)

^v General Hospital of Chania   (Greece)

^w Kalamata General Hospital   (Greece)

^x General Hospital Vostanion of Mytilini   (Greece)

^y G GENNIMATAS GENERAL HOSPITAL   (Greece)

^z General Hospital of Xanthi   (Greece)

^aa General Hospital of Trikala   (Greece)

^ab General Hospital of Arta   (Greece)

^ac General District Hospital of Serres   (Greece)

^ad Social Security Institute of Pireaus   (Greece)

^ae General Hospital of Sparta   (Greece)

^af DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^ag UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^ah Katerini General Hospital   (Greece)

^ai General Hospital of Kavala   (Greece)

^aj General Hospital of Kozani Mamatseio   (Greece)

^ak Hospital Chatzikostas of Ioannina   (Greece)

^al General Hospital of Amaliada   (Greece)

^am General Hospital of Rethymno   (Greece)

^an General Hospital of Kos   (Greece)

^ao KAT HOSPITAL   (Greece)

^ap General Hospital of Tripolis   (Greece)

^aq Children's Hospital of Athens Agia Sofia   (Greece)

more..

Author keywords

Greece; Registry; Sickle cell disease; Thalassaemia

Indexed keywords

ADULT; AGED; ARTICLE; BIOETHICS; BIRTH DEFECT; CAUSE OF DEATH; DEATH; DEMOGRAPHY; DISEASE REGISTRY; EDUCATION; GREECE; HEART DISEASE; HEMOGLOBINOPATHY; HUMAN; LIFE EXPECTANCY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALPRACTICE; MORTALITY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RELIGION; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; SOCIAL ASPECT; THALASSEMIA INTERMEDIA; THALASSEMIA MAJOR;

ABORTION, EUGENIC; ANEMIA, SICKLE CELL; CAUSE OF DEATH; EMIGRANTS AND IMMIGRANTS; FERTILIZATION IN VITRO; GENETIC COUNSELING; GENETIC TESTING; GREECE; HEMOGLOBINOPATHIES; HUMANS; INCIDENCE; INFANT, NEWBORN; PATIENT EDUCATION AS TOPIC; PRENATAL DIAGNOSIS; REGISTRIES; SOCIOECONOMIC FACTORS; THALASSEMIA;

EID: 84864962258     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1465-7     Document Type: Article

References (21)

1. Schizas N, Tegos C, Voutsadakis A, Arabatzis G, Angelopoulou P, Chrysanthopoulos K, Athanasiadou A, Bathrelou S, Rombos J, Skarlos D, Davakis M (1977) The frequency and distribution of β-thalassaemia and abnormal hemoglobins in Greece. A study of 15.000 reruits. Hell Armed ForcesMed Rev 11(suppl 1):197-203
2. Angastiniotis M, Modell B, Englezos P, Boulyjenkov V (1995) Prevention and control of haemoglobinopathies. BullWorld Health Organ 73:375-386
3. Cao A, Rosatelli C, Galanello R (1991) Population-based genetic screening. Curr Opin Genet Dev 1:48-53
4. Scalone L, Mantovani LG, Krol M, Rofail D, Ravera S, Bisconte MG, Borgna-Pignatti C, Borsellino Z, Cianciulli P, Gallisai D, Prossomariti L, Stefàno I, Cappellini MD (2008) Costs, quality of life, treatment satisfaction and compliance in patients with betathalassaemia major undergoing iron chelation therapy: the ITHACA study. Curr Med Res Opin 24(7):1905-1917
5. Pennell DJ, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, Gotsis ED, Tanner MA, Smith GC, Westwood MA, Wonke B, Galanello R (2006) Randomized controlled trial of deferiprone or deferoxamine in beta-thalassaemia major patients with asymptomatic myocardial siderosis. Blood 107:3738-3744
6. Westwood MA, Firmin DN, Gildo M, Renzo G, Stathis G, Markissia K, Vasili B, Pennell DJ (2005) Intercentre reproducibility of magnetic resonance T2*measurements of myocardial iron in thalassaemia. Int J Cardiovasc Imaging 21:531-538
7. Chouliaras G, Berdoukas V, Ladis V, Kattamis A, Chatziliami A, Fragodimitri C, Karabatsos F, Youssef J, Karagiorga-Lagana M (2011) Impact of magnetic resonance imaging on cardiac mortality in thalassaemia major. J Magn Reson Imaging 34:565-569
8. Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ (2008) Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 10:42
9. Modell B, Khan M, Darlison M (2000) Survival in betathalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet 355:2051-2052
10. Telfer P, Coen GP, Christou S, Hadjigavriel M, Kolnakou A, Pangalou E, Pavlides N, Simamonian K, Skordos G, Sitarou M, Angastiniotis M (2006) Survival of medically treated thalassaemia patients in Cyprus. Trends and risk factors over the period 1980- 2004. Haematol 91:1187-1192
11. Borgna-Pignati C, Rugolotto S, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A (2004) Survival and complications in patients with thalassaemia major treated with transfusion and deferoxamine. Haematol 89:1187-1193
12. Ladis V, Chouliaras G, Berdousi H, Kanavakis E, Kattamis C (2005) Longitudinal study of survival and causes of death in patients with thalassaemia major in Greece. Ann N Y Acad Sci 1054:445-450
13. Charafeddine K, Isma'eel H, Charafeddine M, Inati A, Koussa S, Naja M, Taher A (2008) Survival and complications of betathalassaemia in Lebanon: a decade's experience of centralized care. Acta Haematol 120(2):112-116
14. Bazrgar M, Peiravian F, Abedpour F, Karimi M (2011) Causes for hospitalization and death in Iranian patients with β-thalassaemia major. Pediatr Hematol Oncol 28(2):134-139
15. Ladis V, Chouliaras G, Berdoukas V, Chatziliami A, Fragodimitri C, Karabatsos F, Youssef J, Kattamis A, Karagiorga-Lagana M (2011) Survival in a large cohort of Greek patients with transfusion-dependent beta thalassaemia and mortality ratios compared to the general population. Eur J Haematol 86:332-338
16. Voskaridou E, Christoulas D, Bilalis A, Plata E, Varvagiannis K, Stamatopoulos G, Sinopoulou K, Balassopoulou A, Loukopoulos D, Terpos E (2010) The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood 115:2354-2363
17. Angelucci E, Muretto P, Nicolucci A, Baronciani D, Erer B, Gaziev J, Ripalti M, Sodani P, Tomassoni S, Visani G, Lucarelli G (2002) Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassaemia following bone marrow transplantation. Blood 100(1):17-21
18. Borgna-Pignatti C (2007) Surviving with thalassaemia major: the Italian experience. Pediatr Hematol Oncol 24:75-78
19. Borgna-Pignatti C, Vergine G, Lombardo T, Cappellini MD, Cianciulli P, Maggio A, Renda D, Lai ME, Mandas A, Forni G, Piga A, Bisconte MG (2004) Hepatocellular carcinoma in the thalassaemia syndromes. Br J Haematol 124(1):114-117
20. Lovet JM, Burroughs A, Bruix J (2003) Hepatocellural carcinoma. Lancet 362:1907-1917
21. Mancuso A, Sciarrino E, Renda MC, Maggio A (2006) A prospective study of hepatocellular carcinoma incidence in thalassaemia. Hemoglobin 30(1):119-124